article thumbnail

HonorHealth Research Institute First in Southwest to Implant New Stroke Prevention Stent

DAIC

The Neuroguard Integrated Embolic Protection (IEP) system is an experimental treatment for carotid artery stenosis, also known as carotid artery disease, a condition in which fatty-waxy deposits known as plaque builds up and blocks the normal flow of blood in the large arteries on either side of the neck. Designed by Raleigh, N.C.-based

Stents 111
article thumbnail

Absorbable metal stents for vascular use in pediatric cardiology: progress and outlook

Frontiers in Cardiovascular Medicine

The past five years have yielded impressive advancements in fully absorbable metal stent technology. The desired ultimate ability for such devices to treat a vascular stenosis without long-term device-related complications or impeding future treatment continues to evoke excitement in clinicians and engineers alike.

Stents 52
article thumbnail

Abstract TP174: Balloon Expandable Stents versus Self-Expanding Stents for Treatment of Intracranial Arterial Stenosis: A Systematic Review and Meta-Analysis

Stroke Journal

Background:There is limited data regarding the comparison of balloon-expanding stents (BES) and self-expanding stents (SES) for the treatment of intracranial arterial stenosis.Methods:We conducted a systematic review to identify studies that compared SES and BES in patients with symptomatic intracranial arterial stenosis.

Stents 40
article thumbnail

William M. Feinberg Lecture: Asymptomatic Carotid Stenosis: Current and Future Considerations

Stroke Journal

Asymptomatic high-grade carotid stenosis is an important therapeutic target for stroke prevention. Since then, transfemoral/transradial carotid stenting and transcarotid artery revascularization have emerged as alternatives to endarterectomy for revascularization.

article thumbnail

Optimal Minimal Stent Area and Impact of Stent Underexpansion in Left Main Up-Front 2-Stent Strategy

Circulation: Cardiovascular Interventions

BACKGROUND:We previously reported the use of minimal stent area to predict angiographic in-stent restenosis after drug-eluting stent implantation for unprotected left main (LM) disease. mm2for distal LM (area under the curve, 0.57;P=0.15), P=0.15), 8.3 mm2for LAD ostium (area under the curve, 0.62;P=0.02), P=0.02), and 5.7

Stents 40
article thumbnail

Abstract TP185: Resolute Onyx Stent for Symptomatic Intracranial Stenosis: Short and Long-Term Results (R.O.S.S.I.S. Study) With 18-month Follow-Up

Stroke Journal

Introduction:The Resolute Onyx stent has shown promise as an effective treatment for symptomatic intracranial atherosclerotic disease (sICAD), with positive clinical outcomes and low procedural complication rates. Stroke, Volume 55, Issue Suppl_1 , Page ATP185-ATP185, February 1, 2024.

Stents 40
article thumbnail

Patient-specific 3D in vitro modeling and fluid dynamic analysis of primary pulmonary vein stenosis

Frontiers in Cardiovascular Medicine

IntroductionPrimary pulmonary vein stenosis (PVS) is a rare congenital heart disease that proves to be a clinical challenge due to the rapidly progressive disease course and high rates of treatment complications.